Dimension

Team Portfolio Research Perspectives

Manifesto Team Portfolio Research Perspectives

Aspect Biosystems

Building a new class of regenerative medicines

Aspect Biosystems

Aspect is developing a targeted pipeline of bioprinted tissue therapeutics to reimagine regenerative medicine

Founders

Chief Executive Officer

Tamer Mohamed

In The News

Novo-allied Aspect Biosystems nabs $115M for bioprinted tissue therapies

Investing In Aspect Biosystems

Our Thoughts

No items found.

Sign up for dispatches from the frontier of what’s possible.

Email Address

The email you entered is invalid

Thank you! Your submission has been received.

Oops! Something went wrong while submitting the form.

Contact careers Privacy Terms & conditions

© Dimension 2024

Sign up for dispatches from the frontier of what’s possible.

Email Address

The email you entered is invalid

Thank you! Your submission has been received.

Oops! Something went wrong while submitting the form.

Contact careers Privacy Terms & conditions

© Dimension 2024

Novo-allied Aspect Biosystems nabs $115M for bioprinted tissue therapies

Investing In Aspect Biosystems